Literature DB >> 28284028

Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.

Jason P Wong1, Blossom Damania1.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of three human malignancies: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. To persist and replicate within host cells, KSHV encodes proteins that modulate different signaling pathways. Manipulation of cell survival and proliferative networks by KSHV can promote the development of KSHV-associated malignancies. In this review, we discuss recent updates on KSHV pathogenesis and the viral life cycle. We focus on proteins encoded by KSHV that modulate the phosphatidylinositol-4,5-bisphosphate 3 kinase and extracellular signal-regulated kinases 1/2 pathways to create an environment favorable for viral replication and the development of KSHV malignancies.

Entities:  

Keywords:  MAPK/ERK; PI3K/Akt/mTOR; kinase; viral life cycle

Mesh:

Year:  2017        PMID: 28284028      PMCID: PMC5876722          DOI: 10.1515/hsz-2017-0101

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  36 in total

1.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Authors:  D F Martin; B D Kuppermann; R A Wolitz; A G Palestine; H Li; C A Robinson
Journal:  N Engl J Med       Date:  1999-04-08       Impact factor: 91.245

2.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway.

Authors:  M Sabry Hamza; Richard A Reyes; Yoshihiro Izumiya; Ronald Wisdom; Hsing-Jien Kung; Paul A Luciw
Journal:  J Biol Chem       Date:  2004-07-05       Impact factor: 5.157

4.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

5.  High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Deirdre O'Mahony; Kathleen M Wyvill; Victoria Wang; Vickie Marshall; Stefania Pittaluga; Seth M Steinberg; Giovanna Tosato; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

6.  The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.

Authors:  Zhigang Zhang; Wuguo Chen; Marcia K Sanders; Kevin F Brulois; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

7.  Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.

Authors:  Sang-Hoon Sin; Debasmita Roy; Ling Wang; Michelle R Staudt; Farnaz D Fakhari; Dhavalkumar D Patel; David Henry; William J Harrington; Blossom A Damania; Dirk P Dittmer
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

Review 8.  Kaposi sarcoma herpesvirus-associated cancers and related diseases.

Authors:  Priscila H Goncalves; Joseph Ziegelbauer; Thomas S Uldrick; Robert Yarchoan
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

9.  In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Authors:  Agata D'Agostino Mutlu; Lucas E Cavallin; Loïc Vincent; Chiara Chiozzini; Pilar Eroles; Elda M Duran; Zahra Asgari; Andrea T Hooper; Krista M D La Perle; Chelsey Hilsher; Shou-Jiang Gao; Dirk P Dittmer; Shahin Rafii; Enrique A Mesri
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

10.  Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.

Authors:  Louise Giffin; John A West; Blossom Damania
Journal:  mBio       Date:  2015-12-08       Impact factor: 7.867

View more
  5 in total

1.  Cis regulation within a cluster of viral microRNAs.

Authors:  Monika Vilimova; Maud Contrant; Ramy Randrianjafy; Philippe Dumas; Endrit Elbasani; Päivi M Ojala; Sébastien Pfeffer; Aurélie Fender
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

Review 2.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

3.  ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway.

Authors:  Huirong Zhang; Guoxin Ni; Blossom Damania
Journal:  Cell Rep       Date:  2020-04-28       Impact factor: 9.423

4.  HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif.

Authors:  Yingcheng Wu; Hao Chen; Yuyan Chen; Lishuai Qu; Erhao Zhang; Zhou Wang; Yuanyuan Wu; Riyun Yang; Renfang Mao; Cuihua Lu; Yihui Fan
Journal:  Aging (Albany NY)       Date:  2019-04-29       Impact factor: 5.682

5.  Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development.

Authors:  Lu Dai; Luis Del Valle; Wendell Miley; Denise Whitby; Augusto C Ochoa; Erik K Flemington; Zhiqiang Qin
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.